BPGbio

BPGbio is a clinical-stage biopharmaceutical company that utilizes artificial intelligence to develop therapies targeting mitochondrial biology and protein homeostasis. Their proprietary platform integrates a vast biobank with advanced AI to identify drug and diagnostic targets across oncology, neurology, and rare diseases.